Blog

隨著新冠肺炎 (COVID-19) 的全球大流行,對於基礎免疫學和轉譯免疫學的研究與日俱增的重要。

免疫學線上講座—新冠肺炎療法的多變樣貌

The evolving COVID-19 landscape: from fundamentals to new therapeutics


隨著新冠肺炎 (COVID-19) 的全球大流行,對於基礎免疫學和轉譯免疫學的研究與日俱增的重要。


免疫講座-The evolving COVID-19 landscape: from fundamentals to new therapeutics
免疫講座-The evolving COVID-19 landscape: from fundamentals to new therapeutics






透過此線上講座您將會了解


◆ 不同程度病情與症狀的新冠肺炎患者,在病毒感染後所引起的宿主反應差異

◆ 以系統血清學(Systems Serology)的方法探討不同新冠肺炎患者的血清抗體表現

◆ 結合 BCR 定序與 PhIP-Seq 的方式研究抗體與抗原表位


講者

◆ Galit Alter, Professor of Medicine, Harvard Medical School, USA
Using Systems Serology to define correlates of immunity to SARS-CoV-2
Timestamp: 00:07:40
◆ Jake GalsonAlchemab Therapeutics, UK
Deep sequencing of patient BCRs for rapid COVID-19 mAb discovery
Timestamp: 00:36:04
◆ Zeev GechtmanAbcam, USA
Immune-response and cytokine storm in COVID-19
Timestamp: 00:59:00
◆ Julian HiscoxUniversity of Liverpool, UK
Analysis of SARS-CoV-2 in clinical samples and post-mortem tissue and what this tells us about COVID-19 in severe cases
Timestamp: 1:13:50
◆ Paul KellamKymab, UK
Vaccines and monoclonal antibodies to SARS-CoV-2
Timestamp: 1:39:12


主持人

◆ Kovilen Sawmynaden, LifeArc, UK




    abcam 台灣代理—昶安
    abcam 台灣代理—昶安


      回上頁
      發佈者 發佈時間 Sep 07, 2021 瀏覽次數 65
      TOP